pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
lucerastat
Fabry Disease
Ceramide glucosyltransferase
Idorsia Pharmaceutical Ltd
0 catalysts
Phase 2
lucicebtide
Esophageal Cancer
Sapience Therapeutics Inc
0 catalysts
Phase 2
lucinactant
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Lee's Pharmaceutical Holdings Ltd
0 catalysts
← prev
page 227 of 271
next →
131
Pain89
Neurology1
Phase 2
ludotadipep
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FutureChem Co Ltd
0 catalysts
Phase 2
lufepirsen
Nexagon (lufepirsen [INN])
Persistent Corneal Epithelial Defects
Amber Ophthalmics Inc
0 catalysts
Marketed
luliconazole
Luzu (luliconazole)
Tinea Corporis
Bausch Health US LLC
0 catalysts
Phase 2
lumacaftor
Subarachnoid Hemorrhage
Cystic fibrosis transmembrane conductance regulator
Qanatpharma AG
0 catalysts
Marketed
lumasiran
Oxlumo (lumasiran)
Primary Hyperoxaluria Type I
$ALNYALNYLAM PHARMACEUTICALS, INC.
0 catalysts
Phase 2
lunbotinib
lunbotinib [INN]
Non-Small Cell Lung Cancer
Ellipses Pharma Ltd
0 catalysts
pre_registration
lunsotogene parvec
Deafness
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
lusutrombopag
Mulpleta (lusutrombopag)
Thrombocytopenia
$SGIOFSHIONOGI & CO LTD
0 catalysts
Phase 3
lutadenovec autogene + sapecmeran autogene
Metastatic Colorectal Cancer
Nexoplex Bio LLC
0 catalysts
Phase 3
lutetium (177Lu) rosopatamab tetraxetan
lutetium (177Lu) rosopatamab tetraxetan [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 3
lutetium (177Lu) zadavotide guraxetan
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Curium Midco Sarl
0 catalysts
Marketed
lutetium Lu 177 dotatate
Lutathera (lutetium Lu 177 dotatate)
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Somatostatin receptor
Advanced Accelerator Applications SA
0 catalysts
pre_registration
lutetium Lu 177 edotreotide
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
ITM Isotope Technologies Munich SE
0 catalysts
Phase 2
luvesilocin
luvesilocin [INN]
Post Partum Depression (Maternal Depression / Postnatal Depression)
Reunion Neuroscience Inc
0 catalysts
Phase 2
luvixasertib
luvixasertib [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Treadwell Therapeutics Inc
0 catalysts
Phase 2
luvomeran
Cystic Fibrosis
$VERXVertex, Inc.
0 catalysts
Phase 2
luvometinib
luvometinib [INN]
Neurofibromatoses Type I (Von Recklinghausen's Disease)
Shanghai Fosun Pharmaceutical (Group) Co Ltd
0 catalysts
Preclinical
lysergic acid diethylamide
lysergic acid diethylamide [INN]
Unspecified Psychiatric Disorders
PharmaTher Holdings Ltd
0 catalysts
Phase 3
lysergide tartrate
Major Depressive Disorder
$DFTXDefinium Therapeutics, Inc.
0 catalysts
Marketed
mNEXSPIKE
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
pre_registration
mRNA-1010
Seasonal Influenza
$MRNAModerna, Inc.
0 catalysts
Phase 1
mRNA-1215
Nipah Virus (NiV) Infections
$MRNAModerna, Inc.
0 catalysts
Phase 1
mRNA-1365
Human Metapneumovirus Infections
$MRNAModerna, Inc.
0 catalysts
Phase 3
mRNA-1403
Norovirus Infections
$MRNAModerna, Inc.
0 catalysts
Phase 1
mRNA-1574
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$MRNAModerna, Inc.
0 catalysts
Phase 1
mRNA-1644
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$MRNAModerna, Inc.
0 catalysts
Phase 2
mRNA-3705
Methylmalonic Acidemia
$MRNAModerna, Inc.
0 catalysts